Bank of New York Mellon’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-146,052
Closed -$343K 4114
2024
Q1
$343K Buy
146,052
+48,513
+50% +$114K ﹤0.01% 3712
2023
Q4
$184K Sell
97,539
-33,854
-26% -$64K ﹤0.01% 3967
2023
Q3
$180K Buy
131,393
+30,529
+30% +$41.8K ﹤0.01% 3984
2023
Q2
$245K Buy
100,864
+824
+0.8% +$2K ﹤0.01% 3907
2023
Q1
$576K Buy
100,040
+347
+0.3% +$2K ﹤0.01% 3420
2022
Q4
$891K Sell
99,693
-34,798
-26% -$311K ﹤0.01% 3248
2022
Q3
$1.91M Buy
134,491
+19,461
+17% +$277K ﹤0.01% 2884
2022
Q2
$1.68M Sell
115,030
-7,069
-6% -$103K ﹤0.01% 2934
2022
Q1
$2.44M Buy
122,099
+14,799
+14% +$295K ﹤0.01% 2823
2021
Q4
$1.88M Buy
107,300
+13,104
+14% +$229K ﹤0.01% 3030
2021
Q3
$737K Buy
94,196
+7,208
+8% +$56.4K ﹤0.01% 3578
2021
Q2
$895K Buy
86,988
+44,185
+103% +$455K ﹤0.01% 3486
2021
Q1
$560K Sell
42,803
-43
-0.1% -$563 ﹤0.01% 3622
2020
Q4
$602K Buy
42,846
+10,196
+31% +$143K ﹤0.01% 3521
2020
Q3
$388K Buy
32,650
+26,832
+461% +$319K ﹤0.01% 3608
2020
Q2
$88K Sell
5,818
-5,649
-49% -$85.4K ﹤0.01% 3918
2020
Q1
$83K Buy
11,467
+4,101
+56% +$29.7K ﹤0.01% 3881
2019
Q4
$77K Buy
7,366
+57
+0.8% +$596 ﹤0.01% 4049
2019
Q3
$452K Buy
7,309
+823
+13% +$50.9K ﹤0.01% 3582
2019
Q2
$464K Buy
6,486
+2,286
+54% +$164K ﹤0.01% 3635
2019
Q1
$201K Buy
4,200
+230
+6% +$11K ﹤0.01% 3883
2018
Q4
$239K Buy
3,970
+357
+10% +$21.5K ﹤0.01% 3784
2018
Q3
$383K Buy
3,613
+514
+17% +$54.5K ﹤0.01% 3745
2018
Q2
$199K Buy
3,099
+1,345
+77% +$86.4K ﹤0.01% 3918
2018
Q1
$118K Buy
+1,754
New +$118K ﹤0.01% 4016